QuidelOrtho Unveils Results Manager System to Streamline Testing

Company Overview - QuidelOrtho (QDEL) has launched the Results Manager System, aimed at streamlining diagnostic data management and improving laboratory workflow efficiency [1][2] - The system enhances connectivity by integrating test results from multiple sources, facilitating faster and more accurate decision-making [1][3] Product Features - The Results Manager System centralizes diagnostic data management, providing a unified view of patient diagnostics and reducing manual data entry, which minimizes errors [3][4] - It supports real-time quality monitoring and automates workflows with features like auto-verification, thus reducing manual effort [4] - The system is scalable and cost-effective, designed to optimize efficiency and reliability for laboratories of all sizes [4] Industry Prospects - The global in vitro diagnostics market was valued at $108.30 billion in 2024 and is projected to grow at a CAGR of 5.62% from 2025 to 2030, driven by the demand for accurate and rapid diagnostic solutions [5][6] - Key growth drivers include the rising prevalence of chronic and infectious diseases, advancements in diagnostics, and a shift towards value-based healthcare [6] Competitive Landscape - Hologic (HOLX) is expanding its diagnostic portfolio with a focus on women's health and has received CE-marking for its Affirm Contrast Biopsy Software [7] - Abbott (ABT) is innovating in infectious disease diagnostics, with recent WHO approval for its Alinity m MPXV assay for emergency use [8] - Grail (GRAL) is advancing early cancer detection through collaborations aimed at improving access to its multi-cancer early detection test [9]